US29337E1029 - Common Stock
ENLIVEN THERAPEUTICS INC
NASDAQ:ELVN (4/17/2024, 7:00:01 PM)
After market: 17.3 0 (0%)17.3
-1.39 (-7.44%)
Enliven Therapeutics, Inc. operates as a a clinical stage precision oncology company. The company is headquartered in Boulder, Colorado and currently employs 6 full-time employees. The company went IPO on 2020-03-12. The firm focuses on addressing existing and emerging unmet needs with a precision oncology approach. The firm is advancing two parallel lead product candidates, ELVN-001 and ELVN-002, as well as pursuing several additional research stage opportunities. Its first product candidate, ELVN-001, is a potent, highly selective, small molecule kinase inhibitor designed to specifically target the breakpoint cluster region-Abelson (BCR-ABL) gene fusion, the oncogenic driver for patients with chronic myeloid leukemia (CML). Its second product candidate, ELVN-002, is a potent, selective, and irreversible human epidermal growth factor receptor 2 (HER2) inhibitor with activity against various HER2 mutations, including Exon 20 insertion mutations (E20IMs) in non-small cell lung cancer (NSCLC).
ENLIVEN THERAPEUTICS INC
6200 Lookout Road
Boulder COLORADO
P: 17206478519
Employees: 6
Website: https://www.enliventherapeutics.com/
Thursday's session: gap up and gap down stocks
Achieved initial cumulative MMR rate of 44% (7/16) by 12 weeks in response-evaluable patients, which compares favorably to precedent Phase 1 trials of...
BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precision...
BOULDER, Colo., March 28, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precision...
Financing includes participation from new and existing investors Net proceeds, along with existing cash, cash equivalents and marketable securities, are...
ELVN stock results show that Enliven Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Here you can normally see the latest stock twits on ELVN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: